2026 NPPES data Epilepsy Physician NPI 1407099179 M.D., PH.D.
Verify on CMS →

XIANGPING ZHOU, M.D., PH.D.

Epilepsy Physician in SYRACUSE, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
918
Medicare Part D claims · 92 beneficiaries · Epilepsy Physician avg: 878
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
88.3216/100
▲ 5 pts above national avg 83.1 · [object Object]
Industry payments
$229.14
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: XIANGPING ZHOU, M.D., PH.D. is a Epilepsy Physician ([object Object]) practicing in SYRACUSE, New York with a Medicare Part D prescribing footprint of 918 claims across 92 beneficiaries — 8% brand-name prescribing . Their CMS MIPS Final Score of 88.3216/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $229.14 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: XIANGPING ZHOU, M.D., PH.D. reported a CMS MIPS final score of 88.3216 out of 100, above the 83.1 national average, and filed 918 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

XIANGPING ZHOU, M.D., PH.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

XIANGPING ZHOU, M.D., PH.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 04/10/2009

NPI 1407099179

Primary specialty

Epilepsy Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

918 5% vs specialty avg

2023 prescription claims

Specialty avg: 878

MIPS final score

88.3216/100 5.221600000000009% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Epilepsy Physician compares to other specialties among New York providers

New York providers

Epilepsy Physician share within New York

1. Epilepsy Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Epilepsy Physician share within New York

Medicare quality performance — MIPS

XIANGPING ZHOU, M.D., PH.D.'s 2023 MIPS final score plotted against the Epilepsy Physician national average

High performer (top quartile)
MIPS Final Score
88.3216/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Epilepsy Physician) — 88.3216/100 vs national avg 83.1

0%100%National avg83%88.3%
MIPS final score (Epilepsy Physician) — 88.3216/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

XIANGPING ZHOU, M.D., PH.D. is a Epilepsy Physician provider practicing in SYRACUSE, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D., PH.D.. NPI: 1407099179. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

XIANGPING ZHOU, M.D., PH.D. appears in the CMS NPPES registry as a Epilepsy Physician provider holding M.D., PH.D. credentials at 90 PRESIDENTIAL PLZ FL 4, SYRACUSE, NY, 13202, with a listed phone of (315) 464-4243. NPI 1407099179 was issued on 04/10/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ZHOU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 918 prescription claims written by this provider, covering 92 Medicare beneficiaries and totaling roughly $285K in drug spend, split 8% brand-name and 92% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 88.3216/100 for the 2023 performance year (Quality 88.4848, Cost 53.7362), compared with the national average of 83.1.

Epilepsy Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 878 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

90 PRESIDENTIAL PLZ FL 4
SYRACUSE, NY 13202

Provider Details

NPI 1407099179
Specialty Epilepsy Physician
Credentials M.D., PH.D.
Gender Female
NPI Issued 04/10/2009

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

88.3216
Final Score
Avg: 83.1
88.4848
Quality
53.7362
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where XIANGPING ZHOU, M.D., PH.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NEUROLOGY MEDICAL SERVICE GROUP LLP
SYRACUSE, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for XIANGPING ZHOU, M.D., PH.D.. Source: openpaymentsdata.cms.gov.

Total received

$229

Largest payer

SK Life Science, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to XIANGPING ZHOU, M.D., PH.D.. To verify XIANGPING ZHOU, M.D., PH.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

XIANGPING ZHOU, M.D., PH.D. — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 918 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

918
Total Claims
$285K
Total Drug Cost
92
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,118
Total Day Supply
33,012
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$167K
Generic Drug Cost
$117K

Patient Demographics

Average Patient Age
53.3 years
Avg HCC Risk Score
1.34
Gender Split
50% female / 50% male
Age Distribution
<65: 65, 65-74: 20, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levetiracetam
156
Lacosamide
128
Lamotrigine Er
Lamotrigine
105
Oxcarbazepine
78
Lamotrigine
68
Clobazam
56
Levetiracetam Er
Levetiracetam
45
Divalproex Sodium Er
Divalproex Sodium
34
Phenobarbital
32
Topiramate
28

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Epilepsy Physician Overview

How XIANGPING ZHOU, M.D., PH.D. fits within the Epilepsy Physician landscape nationally.

354
Epilepsy Physician Providers in US
42
States with Epilepsy Physician
878
Avg Claims per Provider

XIANGPING ZHOU, M.D., PH.D.'s 918 claims are above the specialty average of 878.

Nearby Epilepsy Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as ZHOU.

Compare Epilepsy Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is XIANGPING ZHOU, M.D., PH.D.'s specialty?
XIANGPING ZHOU, M.D., PH.D. specializes in Epilepsy Physician and practices in SYRACUSE, New York. Credentials: M.D., PH.D..
How much does XIANGPING ZHOU, M.D., PH.D. prescribe under Medicare Part D?
In 2023, XIANGPING ZHOU, M.D., PH.D. wrote 918 Medicare Part D claims totaling $285K in drug costs for 92 beneficiaries.
What is XIANGPING ZHOU, M.D., PH.D.'s Medicare quality score?
XIANGPING ZHOU, M.D., PH.D. has a CMS MIPS Final Score of 88.3216/100 (Quality: 88.4848, Cost: 53.7362). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is XIANGPING ZHOU, M.D., PH.D. located?
XIANGPING ZHOU, M.D., PH.D. is located at 90 PRESIDENTIAL PLZ FL 4, SYRACUSE, NY, 13202. Phone: (315) 464-4243.
What is XIANGPING ZHOU, M.D., PH.D.'s NPI number?
XIANGPING ZHOU, M.D., PH.D.'s National Provider Identifier (NPI) is 1407099179, issued on 04/10/2009.
Does XIANGPING ZHOU, M.D., PH.D. prescribe more brand-name or generic drugs?
XIANGPING ZHOU, M.D., PH.D.'s prescribing is 8% brand-name and 92% generic drugs by claim count, with $167K in brand drug costs.
How many Epilepsy Physician providers are there in the US?
There are 354 Epilepsy Physician providers across 42 states in the US. The average Epilepsy Physician provider writes 878 Medicare Part D claims per year.
What drugs does XIANGPING ZHOU, M.D., PH.D. prescribe most often?
Based on 2023 Medicare Part D data, XIANGPING ZHOU, M.D., PH.D.'s most frequently prescribed drugs include Levetiracetam, Lacosamide, Lamotrigine Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does XIANGPING ZHOU, M.D., PH.D. accept Medicare?
XIANGPING ZHOU, M.D., PH.D. appears in CMS Medicare data with 918 Part D claims and 92 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify XIANGPING ZHOU, M.D., PH.D.'s credentials?
XIANGPING ZHOU, M.D., PH.D.'s NPI is 1407099179 with credentials M.D., PH.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology